Leader Harmonious's harmonic reducers benefit from warming domestic humanoid robot demand, but valuation already prices in an optimistic scenario
AI summary card
Leader Harmonious's harmonic reducers benefit from warming domestic humanoid robot demand, but valuation already prices in an optimistic scenario
Goldman Sachs maintains a Neutral rating on Leader Harmonious Drive Systems Co. with a 12-month target price of Rmb138, believing the company has an 80%-90% share in domestic humanoid robot harmonic gear reducers and a bottleneck position in capacity, but current Rmb488 shares already reflect a long-term bull case.
- Management believes domestic humanoid robot shipments may exceed 50,000 units in 2026, and if subsidy-like policy support for new-energy vehicles is implemented, industry shipments could approach 200,000 units in 2027.
- The company’s share in the Chinese humanoid robot market using harmonic reducers has risen to 80%-90%, and supply tightness has made it one of the key bottlenecks for industry growth.
- Management targets annualized harmonic reducer capacity of 1.44 million units by the end of 2026, with a long-term annualized capacity vision of 10 million units.
- The stock is up 154% year-to-date and trades at 2026E/2027E P/E multiples of 411x/276x; Goldman Sachs believes the market has already priced in a bull scenario.
- Sensitivity analysis under 2030E shipment assumptions of 2 million to 10 million units and ASP of Rmb700 to Rmb2500 implies equity value upside/downside of -67% to +147%.
Report interpretation
Overview
This report is based on a July 3, 2026 conference call with Goldman Sachs and LeaderDrive Investor Relations head Mr. Gui and summarizes domestic humanoid robot demand, the company’s harmonic reducer share, capacity expansion, overseas customer progress, and valuation sensitivity. The report finds the company benefits from expansion in humanoid robots, industrial robots, collaborative robots, CNC machine tools, and other advanced equipment applications, but the current stock price already reflects long-term growth expectations relatively early.
Core views
The core view is that fundamental trends are positive but valuation is significantly constrained. On the demand side, vertical scenarios such as warehousing and logistics, sorting, grocery packaging, and shelf replenishment are expected to commercialize first, supporting domestic humanoid robot shipments in excess of 50,000 units in 2026E; if policy support materializes, 2027E shipments may approach 200,000 units. On the supply side, the company has approximately an 80%-90% share in domestic humanoid robot harmonic reducers and is operating at full capacity, with short-term supply tightness supporting price stability. On valuation, the stock has surged sharply and trades at very high forward PE multiples; Goldman Sachs believes the market is already reflecting bull and even long-term scenarios, so it maintains a Neutral rating.
Analysis framework
The report performs valuation sensitivity testing through management interviews, industry shipment scenarios, capacity planning, ASP assumptions, margin and exit multiple analysis, and compares current market capitalization against a potential 2030E equity value range.
Methodology notes
Estimates a range of equity value using 2030E humanoid robot-related shipments, ASP, net margin, exit P/E multiple, and cost of equity.
Goldman Sachs assumes 2030E shipments between 2 million and 10 million units, ASP between Rmb700 and Rmb2500, related-business net margin of 25%, an exit P/E multiple of 45x in 2030E, and discounts cash flows at 11.5% cost of equity.
A Neutral rating means the stock is not included in the Buy or Sell list within the relevant coverage universe.
While the report is constructive on the company’s long-term TAM expansion and customer penetration, it believes the current share price already reflects a relatively optimistic long-term forecast, so it remains Neutral.
Compares stock attributes by growth, financial return, valuation multiples, and composite percentile.
The report states that the Goldman Sachs factor framework uses sales, EBITDA, and EPS growth as well as ROE, ROCE, CROCI, and P/E, P/B, and EV/EBITDA metrics for market and peer-industry comparison.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- Leader Harmonious Drive Systems Co. (688017.SS)Primary company covered in the report, a leading domestic harmonic reducer manufacturer.
- Strengths
- High share in Chinese humanoid robot harmonic reducers, and clients rely more on high-quality suppliers as they move from R&D toward early commercialization; fast capacity expansion, and strong supply-chain relationships and scale advantages.
- Weaknesses
- Current valuation is very high and shares have risen sharply; maturity gaps in key components for high-precision dexterous hands limit some applications.
- Comparison
- Compared with smaller peers, the company’s expansion is faster and smoother; compared with global peers, quality is close and pricing is more competitive.
- Risks
- If domestic industrial/collaborative robot demand falls short of expectations, or if competition intensifies from domestic and overseas brands, profitability and valuation could come under pressure.
- SKFPlanning a joint venture with LeaderDrive in China, with SKF holding 60% and LeaderDrive holding 40%.
- Strengths
- The JV focuses on high-precision drivetrain components for humanoid robots and can leverage SKF’s global sales network to serve Chinese and international markets.
- Weaknesses
- Planned to start operations at the end of 2026, short-term revenue contribution remains unproven.
- Comparison
- SKF can provide crossed roller bearings, spherical roller bearings, and deep-groove ball bearings, and collaborate with LeaderDrive on lightweight design and manufacturing technology.
- Risks
- Uncertainty around JV implementation, customer onboarding, and overseas demand pace.
- Chinese humanoid robot supply chainCore downstream for the company’s demand growth.
- Strengths
- Warehousing and logistics, sorting, and grocery retail dedicated scenarios have relatively early commercialization potential, while policy subsidies could accelerate scaling.
- Weaknesses
- High-precision operation applications are not yet mature; reliability and lifetime of dexterous-hand key components remain bottlenecks.
- Comparison
- Potential subsidies are likened to the new-energy vehicle subsidy policy in 2009-2010.
- Risks
- Policy not being implemented, production ramp slower than expected, or delayed confirmation of end-customer orders.
Key data
- 12-month target priceRmb138.00Based on 2030E 45x P/E discounted at 11.5% cost of equity to 2027E.
- Current priceRmb488.00Price disclosed on the front page of the report.
- Implied downside71.7%Downside to target price versus current price.
- Market valueRmb89.5bn / $13.2bnKey data point in the report.
- 2026E domestic humanoid robot shipments>50k units; Goldman Sachs base case 51kVertical or dedicated applications may commercialize more quickly.
- 2027E domestic humanoid robot shipment scenarioCompany sees potential around 200k; Goldman Sachs base/bull/blue-sky 76k/148k/220kDepends on whether policy support similar to new-energy vehicle subsidies is implemented.
- Domestic humanoid robot harmonic reducer share80%-90%Higher than roughly 70% in the prior year.
- 2026 year-end annualized capacity target1.44mn unitsMonthly capacity target is about 120k units.
- Long-term annualized capacity vision10mn unitsThe ramp-up pace depends on demand, domestic equipment substitution, and manufacturing know-how.
- 2026E/2027E P/E411x / 276xThe report argues valuation indicates the stock is trading more on long-term prospects.
- Valuation sensitivity range-67% to +147%Based on 2030E shipments of 2 million to 10 million units and ASP of Rmb700 to Rmb2500.
Impact & implications
The implication for investors is that the company is a core scarce name in China’s humanoid robot drivetrain value chain, benefiting in the near term from rising demand, tight supply, and stable pricing. However, the current stock price already assumes high expectations for long-term capacity, shipments, and ASP; if policy, orders, or overseas customer progress fall short, valuation pullback risk is substantial.
Risks
- Upside risk includes faster-than-expected mass production or technology progress in humanoid robots.
- Upside risk includes faster penetration of key robot customers, especially overseas brands.
- Downside risk includes domestic industrial robot and collaborative robot demand falling short of expectations.
- Downside risk includes intensified competitive pressure from overseas and domestic brands.
- High valuation already reflects an optimistic long-term scenario; if orders, policy, or capacity ramping fail to meet expectations, stock pullback risk is elevated.
- Some high-precision applications remain constrained by reliability and service life of dexterous-hand key components.
What to watch
- Whether China introduces humanoid robot industry policy in 2026 similar to new-energy vehicle subsidies.
- Whether domestic humanoid robot shipments in 2026E exceed 50k units and whether 2027E approaches 200k.
- Whether monthly capacity rises as planned from about 70k in May 2026 and about 80k in June to 120k by year-end.
- Whether harmonic reducer prices remain stable amid ongoing supply tightness.
- Whether North American customers move from outlook to clearly confirmed large-scale orders.
- Progress and outcomes of the SKF JV launch and overseas customer expansion.
- Small-batch and channel progress with international industrial robot customers such as Yaskawa, ABB, and Fanuc.
- Second-half 2026 ramp-up and delivery performance for planetary reducers.